Qiagen NV- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於公司

公司簡介

公司代碼QGEN

公司名稱Qiagen NV

上市日期Sep 01, 1996

CEOMr. Thierry Bernard

員工數量5765

證券類型Ordinary Share

年結日Sep 01

公司地址Hulsterweg 82

城市VENLO

上市交易所NYSE Consolidated

國家Netherlands

郵編5912 PL

電話31773556600

網址https://www.qiagen.com/

公司代碼QGEN

上市日期Sep 01, 1996

CEOMr. Thierry Bernard

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Roland Sackers

Managing Director, Chief Financial Officer, Member of the Executive Board

383.09K

+59.93%

Mr. Thierry Bernard

Chief Executive Officer, Managing Director, Member of the Executive Board

312.13K

+75.76%

Dr. Metin Colpan, Ph.D.

Independent Member of the Supervisory Board

171.79K

-57.00%

Tallett (Elizabeth E)

Independent Member of the Supervisory Board

47.22K

+10.37%

Prof. Dr. Ross L. Levine, M.D.

Independent Member of the Supervisory Board

16.27K

+30.83%

Prof. Dr. Elaine R. Mardis, Ph.D.

Independent Member of the Supervisory Board

3.97K

--

Mr. Stephen H. (Steve) Rusckowski

Independent Chairman of the Supervisory Board

24.00

--

Ms. Eva van Pelt

Independent Member of the Supervisory Board

--

Dr. Toralf Haag, Ph.D.

Independent Member of the Supervisory Board

--

Mr. Bert van Meurs

Independent Member of the Supervisory Board

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Roland Sackers

Managing Director, Chief Financial Officer, Member of the Executive Board

383.09K

+59.93%

Mr. Thierry Bernard

Chief Executive Officer, Managing Director, Member of the Executive Board

312.13K

+75.76%

Dr. Metin Colpan, Ph.D.

Independent Member of the Supervisory Board

171.79K

-57.00%

Tallett (Elizabeth E)

Independent Member of the Supervisory Board

47.22K

+10.37%

Prof. Dr. Ross L. Levine, M.D.

Independent Member of the Supervisory Board

16.27K

+30.83%

Prof. Dr. Elaine R. Mardis, Ph.D.

Independent Member of the Supervisory Board

3.97K

--

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

業務USD

名稱

營收

佔比

Consumables and Related Revenues

435.06M

89.99%

Instrumentation

48.39M

10.01%

地區USD

名稱

營收

佔比

United States

232.85M

48.16%

Europe & Middle East & Africa

160.64M

33.23%

Asia, Pacific & Rest of the World

68.83M

14.24%

Other Americas

21.13M

4.37%

業務

地區

業務USD

名稱

營收

佔比

Consumables and Related Revenues

435.06M

89.99%

Instrumentation

48.39M

10.01%

股東統計

更新時間: 9月11日週四

持股股東

股東類型

持股股東

佔比

Wellington Management Company, LLP

12.00%

MFS Investment Management

10.83%

BlackRock Institutional Trust Company, N.A.

9.47%

The Vanguard Group, Inc.

4.22%

T. Rowe Price International Ltd

2.74%

其他

60.74%

持股股東

佔比

Wellington Management Company, LLP

12.00%

MFS Investment Management

10.83%

BlackRock Institutional Trust Company, N.A.

9.47%

The Vanguard Group, Inc.

4.22%

T. Rowe Price International Ltd

2.74%

其他

60.74%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

47.08%

Investment Advisor

32.87%

Research Firm

4.24%

Sovereign Wealth Fund

1.64%

Pension Fund

1.60%

Hedge Fund

1.43%

Holding Company

1.17%

Bank and Trust

1.02%

Individual Investor

0.44%

其他

8.50%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

996

189.55M

87.53%

+6.64M

2025Q1

1017

179.03M

82.67%

+27.58M

2024Q4

1010

129.03M

59.70%

-70.06M

2024Q3

1010

183.22M

84.72%

-23.62M

2024Q2

1002

184.34M

84.75%

+8.40M

2024Q1

988

165.20M

76.61%

-7.18M

2023Q4

993

165.11M

76.72%

-10.52M

2023Q3

987

159.93M

74.32%

-12.21M

2023Q2

996

162.43M

75.49%

-6.05M

2023Q1

1001

160.07M

74.44%

-9.45M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Wellington Management Company, LLP

24.44M

11.29%

+1.15M

+4.92%

Mar 31, 2025

MFS Investment Management

24.26M

11.2%

+24.26M

--

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

20.17M

9.31%

-350.47K

-1.71%

Jun 16, 2025

The Vanguard Group, Inc.

8.78M

4.06%

+245.16K

+2.87%

Mar 31, 2025

T. Rowe Price International Ltd

4.15M

1.92%

+4.01M

+2888.12%

Mar 31, 2025

EARNEST Partners, LLC

3.81M

1.76%

+3.81M

--

Mar 31, 2025

Amundi Asset Management, SAS

4.19M

1.94%

-516.05K

-10.96%

Mar 31, 2025

Swedbank Robur Fonder AB

3.06M

1.41%

+186.76K

+6.51%

May 31, 2025

Norges Bank Investment Management (NBIM)

3.96M

1.83%

-111.67K

-2.74%

Dec 31, 2024

持股ETF

更新時間: 9月6日週六

機構名稱

佔比

ROBO Global Healthcare Technology & Innovation ETF

1.62%

Zacks Small/Mid Cap ETF

0.71%

Fidelity International Multifactor ETF

0.4%

iShares ESG Advanced MSCI EAFE ETF

0.12%

iShares MSCI World ETF

0.01%

iShares Russell 2500 ETF

0%

SPDR MSCI EAFE StrategicFactors ETF

0%

iShares MSCI ACWI ex U.S. ETF

0%

Vanguard ESG International Stock ETF

0%

Global X Genomics & Biotechnology ETF

0%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.62%

Zacks Small/Mid Cap ETF

佔比0.71%

Fidelity International Multifactor ETF

佔比0.4%

iShares ESG Advanced MSCI EAFE ETF

佔比0.12%

iShares MSCI World ETF

佔比0.01%

iShares Russell 2500 ETF

佔比0%

SPDR MSCI EAFE StrategicFactors ETF

佔比0%

iShares MSCI ACWI ex U.S. ETF

佔比0%

Vanguard ESG International Stock ETF

佔比0%

Global X Genomics & Biotechnology ETF

佔比0%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

公告日期

類型

比率

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

Qiagen NV

43.900USD

Qiagen NV

43.900

概覽

公司

財務

分析